Well said. And as Tom mentions in the release, the team completed the study protocol and SAP within three months of obtaining final EMA feedback.
Not sure if anyone here has been involved in the completion of study protocol/SAP plan for a Phase 3 trial, but I can tell you that this is quick.
- Forums
- ASX - By Stock
- IXC
- Ann: Invex Files Pre-IND/Type B Meeting Request with US FDA
Ann: Invex Files Pre-IND/Type B Meeting Request with US FDA, page-5
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.5¢ |
Change
0.001(1.35%) |
Mkt cap ! $5.636M |
Open | High | Low | Value | Volume |
7.5¢ | 7.5¢ | 7.5¢ | $174 | 2.318K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 108682 | 7.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.8¢ | 8695 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 108682 | 0.075 |
1 | 27158 | 0.074 |
1 | 49983 | 0.072 |
1 | 84879 | 0.067 |
1 | 100000 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.078 | 8695 | 1 |
0.080 | 73445 | 2 |
0.083 | 40000 | 1 |
0.090 | 126146 | 1 |
0.095 | 100000 | 1 |
Last trade - 10.04am 27/09/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |